Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases (Q38561490)

From Wikidata

Jump to navigation Jump to search

scientific article published on 06 August 2015

Language	Label	Description	Also known as
English	Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases	scientific article published on 06 August 2015

Statements

scholarly article

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases (English)

1 reference

Europe PubMed Central

4 September 2017

0 references

hydroxychloroquine

0 references

rheumatoid arthritis

0 references

lupus erythematosus

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

1 reference

based on heuristic

inferred from title

author name string

K D Rainsford

1

1 reference

Europe PubMed Central

4 September 2017

Ann L Parke

2

1 reference

Europe PubMed Central

4 September 2017

Matthew Clifford-Rashotte

3

1 reference

Europe PubMed Central

4 September 2017

W F Kean

4

1 reference

Europe PubMed Central

4 September 2017

publication date

6 August 2015

1 reference

Europe PubMed Central

4 September 2017

Inflammopharmacology

1 reference

Europe PubMed Central

4 September 2017

23

1 reference

Europe PubMed Central

4 September 2017

5

1 reference

Europe PubMed Central

4 September 2017

231-269

1 reference

Europe PubMed Central

4 September 2017

https://scigraph.springernature.com/pub.10.1007/s10787-015-0239-y

0 references

Severe hydroxychloroquine myopathy

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: A Proof of Concept Study

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The effect of some anti-inflammatory agents on elastase release from neutrophils in-vitro

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The effect of chloroquine on paracetamol disposition and kinetics

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Reduced ampicillin bioavailability following oral coadministration with chloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Ammonium chloride, methylamine and chloroquine reversibly inhibit antibody secretion by plasma cells

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effect of antiinflammatory drugs on human interleukin-1-induced cartilage degradation

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Stimulation of polymorphonuclear leucocyte phospholipase A2 activity by chloroquine and mepacrine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Long-term effectiveness of antimalarial drugs in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Receptor-mediated binding of leukocyte elastase by chondrocytes

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The effects of colchicine and hydroxychloroquine on the cyclo-oxygenases COX-1 and COX-2.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine: from malaria to autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis. An open 3-year study

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The Arthus reaction in guinea-pig knee joints. A test for anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The potential place of chloroquine in the treatment of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine accumulates in breast-milk cells: potential impact in the prophylaxis of postnatal mother-to-child transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Antimalarial drugs in systemic lupus erythematosus: use in pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS-II. SOME EFFECTS ON SULPHATE-35S METABOLISM IN VIVO.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Antibody-mediated infection of P388D1 cells with 17D yellow fever virus: effects of chloroquine and cytochalasin B.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Presentation of cartilage proteoglycan to a T cell hybridoma derived from a mouse with proteoglycan-induced arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effect of antimalarial drugs on stimulation and interleukin 2 production of human lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effects of hydroxychloroquine on salivary flow rates and oral complaints of Sjögren patients: a prospective sample study

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Assessment of anti-inflammatory drugs in the rat using subcutaneous implants of polyurethane foam impregnated with dead tubercle bacilli

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

A new model of osteoarthritis in rabbits. II. Evaluation of anti-osteoarthritic effects of selected antirheumatic drugs administered systemically

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Evidence of transplacental passage of hydroxychloroquine in humans

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: A study of one hundred thirty‐three cases compared with a control group

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Biochemical properties of anti-inflammatory drugs. VII. Inhibition of proteolytic enzymes in connective tissue by chloroquine (resochin) and related antimalarial antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Pharmacogenetics: implications for therapy in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Heart rate variability in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine therapy in patients with primary Sjögren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Stereoselective determination of hydroxychloroquine and its metabolites in human urine by liquid-phase microextraction and CE.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Towards evidence-based treatment of thrombotic antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Biochemical indices of response to hydroxychloroquine and sodium aurothiomalate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Antimalarials in the management of discoid and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Excretion of chloroquine, dapsone and pyrimethamine in human milk

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effect of experimental diabetes mellitus and arthritis on the pharmacokinetics of hydroxychloroquine enantiomers in rats

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine in human milk

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine elimination in humans: effect of low-dose cimetidine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Prevention by chloroquine of hexosamine cartilage depletion by E-prostaglandins

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Respiratory function in systemic lupus erythematosus: relation with activity and severity.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

In vitro hexosamine depletion of intact articular cartilage by E-prostaglandins: prevention by chloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Occasional series: lupus around the world systemic lupus erythematosus research in the Asia-Pacific region: a co-ordinated and co-operative approach

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Antiplatelet drugs: clinical pharmacology and therapeutic use.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

CYP2C8 and antimalaria drug efficacy

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Current concepts and new ideas on the mechanism of action of quinoline-containing antimalarials

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Rapid isolation of rat liver secondary lysosomes--autophagic vacuoles--following chloroquine administration

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Combination therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effects of piroxicam on mononuclear cells. Comparison with other antiarthritic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine and visual screening in a rheumatology outpatient clinic

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Retinal toxicity secondary to Plaquenil therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Lysosomes, pH and the Anti-malarial Action of Chloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Studies on the mechanism of phospholipid storage induced by amantadine and chloroquine in Madin Darby canine kidney cells

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine enhances the number of IL-10 producing cells and the expression of B7-2 and ICAM-1 in in vitro-cultured PBMC.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Pharmacological studies of antigen-induced arthritis in BALB/c mice. II. The effects of second-line antirheumatic drugs and cytotoxic agents on the histopathological changes

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Studies on the mechanism of inhibition of chemotactic tripeptide stimulated human neutrophil polymorphonuclear leucocyte superoxide production by chloroquine and hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

SUPPRESSION OF IN VITRO LYMPHOCYTE RESPONSES BY CHLOROQUINE.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Dissimilar effects of anti-inflammatory drugs on stability of lysosomes from peritoneal and circulating leukocytes and liver

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effect of chloroquine on the bioavailability of ciprofloxacin in man.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effect of chloroquine on the urinary excretion of ciprofloxacin

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The inhibition of gluconeogenesis by chloroquine contributes to its hypoglycaemic action.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine: its effect on leucocyte auto- and heterophagocytosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The presence of abnormal lysosomes in lymphocytes and neutrophils during chloroquine therapy: a quantitative ultrastructural study

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Interactions of prednisolone and other immunosuppressants used in dual treatment of systemic lupus erythematosus in lymphocyte proliferation assays

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Selective elution of HLA antigens and beta 2-microglobulin from human platelets by chloroquine diphosphate

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine- and primaquine-induced alterations of glucose metabolism in the uninfected red cell

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effect of gold salts and antimalarials on the rheumatoid factor in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Drug-induced alterations of tumor necrosis factor-mediated cytotoxicity: discrimination of early versus late stage action

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Dosage of Antimalarial Drugs for Children with Juvenile Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Clinical Study with Determination of Serum Concentrations of Chloroquine and Hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The effect of adjuvant arthritis and drugs on the ability of rat plasma to inhibit the triton X-100 induced lysis of rabbit polymorphonuclear leucocyte granules

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The antimalarials quinacrine and chloroquine induce weak lysosomal storage of sulphated glycosaminoglycans in cell culture and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

In vitro binding of chloroquine to rat muscle preparations

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Role of Lysosomes in Hepatic Accumulation of Chloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

An appraisal of chloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Antimalarial drugs for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Pharmacologic actions of 4-aminoquinoline compounds

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Antimalarials in rheumatology: efficacy and safety

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effect of adenosine triphosphate and some anti-inflammatory agents on a purified lysosomal fraction having high acid phosphatase and labile -glucuronidase activity

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine, quinine, procaine, quinidine and clomipramine are prostaglandin agonists and antagonists

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Metabolism of chloroquine and hydroxychloroquine in albino and pigmented rats

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Tissue distribution of chloroquine, hydroxychloroquine, and desethylchloroquine in the rat

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Clinical image: blonde by prescription

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The impact of stereoisomerism in bioequivalence studies

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effect of hydroxychloroquine on the lipid profile of patients with Sjögren syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Antioxidant action of antimalarials

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The amplified chemiluminescence test to characterize antirheumatic drugs as oxygen radical scavengers

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Differences in anti-malarial activity of 4-aminoalcohol quinoline enantiomers and investigation of the presumed underlying mechanism of action

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Excretion of hydroxychloroquine in human milk

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Inhibition by nonsteroidal anti-inflammatory drugs of superoxide production and granule enzyme release by polymorphonuclear leukocytes stimulated with immune complexes or formyl-methionyl-leucyl-phenylalanine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Retina in rheumatic diseases: standard full field and multifocal electroretinography in hydroxychloroquine retinal dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Independent effects of interleukin 1 on proteoglycan synthesis and proteoglycan breakdown of bovine articular cartilage in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Estimated 10-year cardiovascular risk in a British population: results of a national screening project

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Action of chloroquine phosphate in rheumatoid arthritis. II. Chromosome damaging effect

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

CHEMOTHERAPY OF ARTHRITIS INDUCED IN RATS BY MYCOBACTERIAL ADJUVANT

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effect of indomethacin and related drugs on the calcium ion-dependent secretion of lysosomal and other enzymes by neutrophil polymorphonuclear leucocytes in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Electron microscopy of lysosomerich fractions from rat liver

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The contributions of various chloroquine salts to the biliary and urinary execretion of hepatic paracetamol conjugation metabolites in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Excretion of chloroquine and desethylchloroquine in human milk

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Inhibition by various antiarthritic agents of murine splenic B cell colony formation

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine in human breast milk

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Action of chloroquine phosphate in rheumatoid arthritis. 1. Immunosuppressive effect

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Changes in brain polyphosphoinositide metabolism induced by cationic amphiphilic drugs in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Antimalarial agents compared with or in combination with other disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Biochemical characterization of ADP-ribose polymer metabolism in SLE.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Lupus in Baltimore: evidence-based 'clinical pearls' from the Hopkins Lupus Cohort

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine inhibits tumor necrosis factor production by human macrophages in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effects of antimalarial drugs on interleukin 1-induced cartilage proteoglycan degradation in-vitro

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Induction of selective acid hydrolase release from mouse macrophages during exposure to chloroquine and quinine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Hydroxychloroquine: the cornerstone of lupus therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Antimalarial drugs in the treatment of rheumatological diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Immunosuppressive potential of antimalarials

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Rheumatoid arthritis medications and lactation

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Impact of chloroquine on viral load in breast milk

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Outcome measures for primary Sjögren's syndrome: a comprehensive review

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effects of antirheumatoid drugs on the production and action of porcine catabolin

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Efficiency of combined methotrexate/chloroquine therapy in adjuvant-induced arthritis.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Influence of hydroxychloroquine on the bioavailability of oral metoprolol

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Studies of the mechanism of chloroquine binding to synthetic DOPA-melanin

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effects of chloroquine and its enantiomers on the development of rat embryos in vitro.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Clinical pharmacokinetics of slow-acting antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Bioavailability of hydroxychloroquine tablets in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Antimalarials in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemate.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Regulation of cellular function by products of lysosomal enzyme activity: elimination of human natural killer cells by a dipeptide methyl ester generated from L-leucine methyl ester by monocytes or polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretion

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Influence of Anti-rheumatic Drugs on Urinary Excretion of Hydroxyproline in Lathyrism

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Role of monocytes in anti-CD3-induced T-cell DNA synthesis: effect of chloroquine and monensin on anti-CD3-induced human T-cell activation

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage. Role of endogenous IL-1 inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Aurothiomalate and hydroxychloroquine inhibit nitric oxide production in chondrocytes and in human osteoarthritic cartilage

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Clinical pharmacokinetics of antimalarial drugs

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Evaluation of potential antirheumatic drugs in vitro using lymphocytes and epithelial cells. The selective action of indoxole, methyl glyoxal and chloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Biochemical properties of anti-inflammatory drugs. VI. The effects of chloroquine (resochin), mepacrine (quinacrine) and some of their potential metabolites on cartilage metabolism and oxidative phosphorylation

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effects of therapeutic drugs on lymphocyte transformation

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Synthesis and preliminary pharmacological evaluation of asymmetric chloroquine analogues

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Idiotype-induced T cell stimulation requires antigen presentation in association with HLA-DR molecules

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Chloroquine differentially modulates inflammatory cytokine expression in RAW 264.7 cells in response to inactivated Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-015-0239-Y

21 January 2018

Effect of chloroquine on the development of wadding granuloma and on granulomatous pocket

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous determination of chloroquine, amodiaquine and their metabolites in human plasma, red blood cells, whole blood and urine by column liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinopathy following chloroquine therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is corneal deposition of antimalarial any indication of retinal toxicity?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimalarial drugs in the treatment of rheumatological diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of pharmacokinetic interaction between chloroquine and imipramine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of action of hydroxychloroquine as an antirheumatic drug

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of aspirin, paracetamol and analgin on pharmacokinetics of chloroquine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of various anti-inflammatory and anti-rheumatic agents on the synthesis, secretion, and activity of a cartilage proteoglycan-degrading enzyme and other macrophage enzymes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concentration dependency of cyclosporin and chloroquine as inhibitors of cell proliferation and immunoglobulin production upon mitogen stimulation of mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intra-articular chloroquine in rheumatoid and osteo-arthritis of knee joint

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analytical and semi-preparative high-performance liquid chromatographic separation and assay of hydroxychloroquine enantiomers

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of cloned cytotoxic lymphocytes with NK-like activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxychloroquine at the recommended dose (< or = 6.5 mg/kg/day) is safe for the retina in patients with rheumatoid arthritis and systemic lupus erythematosus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular toxicity of hydroxychloroquine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible efficacy of hydroxychloroquine on accelerated nodulosis during methotrexate therapy for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of antirheumatic agents on the mitogen response of arthritic rat spleen cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokines in rheumatic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipramine and chloroquine induced alterations in phospholipid content of rat lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble interleukin 2 receptors and treatment with hydroxychloroquine in erosive osteoarthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term use of antimalarial drugs in rheumatic diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxychloroquine in the treatment of erosive osteoarthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor-mediated endocytosis of immunoglobulin-coated colloidal gold particles in cultured mouse peritoneal macrophages. Chloroquine and monensin inhibit transfer of the ligand from endocytic vesicles to lysosomes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease-modifying antirheumatic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of hydroxychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimalarial agents: closing the gate on Toll-like receptors?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of some anti-inflammatory (anti-rheumatic) drugs on the metabolism of connective tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for antimalarial toxicity: current concepts

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective iNOS inhibitor 1400W enhances anti-catabolic IL-10 and reduces destructive MMP-10 in OA cartilage. Survey of the effects of 1400W on inflammatory mediators produced by OA cartilage as detected by protein antibody array.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabolism of chloroquine in man during and after repeated oral dosage

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer cell function in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokines as genetic modifying factors in immune and inflammatory diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placental and milk transfer of chloroquine in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of antimalarials in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of chloroquine on edema induced by ovalbumin and dextran and on Ambrose and Eds test in rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chloroquine and hydroxychloroquine inhibit multiple sites in metabolic pathways leading to neutrophil superoxide release

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The history of antimalarials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy with hydroxychloroquine and methotrexate in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Canadian Consensus Conference on hydroxychloroquine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimalarial activity of the optical isomers of chloroquine diphosphate

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chloroquine treatment and bone changes in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of antimalarials in rheumatoid arthritis--the British experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The chemosuppression of chemotaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of controlled clinical trials examining the effects of antimalarial compounds and gold compounds on radiographic progression in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of anti-malarials in rheumatoid arthritis--the American experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro effect of chloroquine, mefloquine and quinine on human lymphocyte proliferative responses to malaria antigens and other antigens/mitogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cartilage destruction by matrix degradation products

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and cellular uptake of 4-aminoquinoline antimalarials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

THE EFFECT OF CHLOROQUINE ON ANTIBODY PRODUCTION

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimalarial drugs, pregnancy and lactation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Effect of Salicylate and Chloroquine on Prostaglandin-Induced Articular Damage in the Rabbit Knee

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of cell association of chloroquine to leucocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AFFINITY OF HYDROXYCHLOROQUINE FOR ARTICULAR TISSUES

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of other drugs and chemicals on the degradation of aspirinin vitro: Possible extrapolation toin vivo metabolism of aspirin

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte proliferative response and subset profiles during extended periods of chloroquine or primaquine prophylaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme Release from Guinea-pig Polymorphonuclear Leucocyte Lysosomes Inhibited in vitro by Anti-Inflammatory Drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of chloroquine on erythematous response to phenol in chronic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conjunctival nodule in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of fat-soluble compounds on lysosomes in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of juvenile arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chloroquine inhibits proinflammatory cytokine release into human whole blood.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of chloroquine and other substances on the collagenolytic activity in human osteoarthritic cartilage in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of lysosomal phospholipase A and phospholipase C by chloroquine and 4,4'-bis(diethylaminoethoxy) alpha, beta-diethyldiphenylethane

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insights from pharmacokinetic and pharmacodynamic studies of hydroxychloroquine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The separation and characterization of subcellular particles

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracellular localization of chloroquine in the liver and kidney of the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of chloroquine on the degradation of L-fucose and the polypeptide moiety of plasma membrane glycoproteins.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum IL-1beta levels are associated with the presence of erosions in recent onset rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Action of antirheumatic drugs on the function of human leucocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of hydroxychloroquine on symptoms of knee osteoarthritis: a double-blind randomized controlled clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of a pharmacokinetic interaction between azithromycin and chloroquine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible mechanisms of action of antimalarials in rheumatic disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of cycloheximide and chloroquine on insulin receptor metabolism. Differential effects on receptor recycling and inactivation and insulin degradation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo effects of chloroquine treatment on spontaneous and interferon-induced natural killer activities in rheumatoid arthritis patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LABILIZATION AND STABILIZATION OF LYSOSOMES

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of lupus erythematosus with mepacrine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of the stereoisomers of hydroxychloroquine and its major metabolites in plasma and urine following a single oral administration of racemic hydroxychloroquine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of anti-inflammatory drugs on catabolin-induced cartilage destruction in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy of juvenile rheumatoid arthritis with hydroxychloroquine-gold-methotrexate: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Collaboration between human blood dendritic cells and monocytes in antigen presentation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies of the metabolism of some compounds of the 4-amino-7-chloroquinoline series.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chloroquine inhibits elastase enzyme activity in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of chloroquine and monodesethylchloroquine in hair.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue distribution of chloroquine in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression of human polymorphonuclear leucocyte function by anti-malarial drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the effects of pharmacological agents on antigen-induced arthritis in BALB/c mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chloroquine: mechanism of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chloroquine: protective and destructive effects on injured rabbit cartilage in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimizing combination chemotherapy for rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weak-base induced lysosomal secretion by macrophages: an alternative trigger mechanism that is independent of complement activation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactions of antirheumatic drugs with the superoxide generation system of activated human polymorphonuclear leukocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management and prognosis of systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxychloroquine-induced fatal toxic epidermal necrolysis complicated by angioinvasive rhizopus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity of antimalarial drugs in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for a relationship between chloroquine and complement from studies with lymphocyte mitogens: possible implications for the mechanism of action of chloroquine in disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes of mucopolysaccharase, protease and collagenolytic activities in rats with adjuvant arthritis and the effects of various anti-inflammatory drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of cholestyramine and chloroquine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent developments in the understanding of the pharmacokinetics and mechanism of action of chloroquine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of chloroquine and its major metabolite in blood using perfluoroacylation followed by fused-silica capillary gas chromatography with nitrogen-sensitive detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular Changes Induced by Long-Term Hydroxychloroquine (Plaquenil) Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chloroquine metabolism in man: urinary excretion of 7-chloro-4-hydroxyquinoline and 7-chloro-4-aminoquinoline metabolites

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of ranitidine on chloroquine disposition

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current practice in antimalarial drug prescribing in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Collagen degradation in an experimental inflammatory lesion: studies on the role of the macrophage

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of phagocytosis by and lysosomal enzyme secretion from guinea-pig neutrophils: effect of nonsteroid anti-inflammatory agents and prostaglindins

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on the biochemistry of heart valves. I. On the biosynthesis of mucopolysaccharides in bovine heart valves

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chloroquine therapy in psoriatic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary metabolism of chloroquine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of chloroquine diphosphate in the dog.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of proteoglycans in rat ovarian granulosa cell culture. Multiple intracellular degradative pathways and the effect of chloroquine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of chloroquine and its metabolites in urine: a field method based on ion-pair extraction

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Release of neutral protease and beta-glucuronidase from human neutrophils in the presence of cartilage treated with various immunologic reactants

1 reference

https://pubmed.ncbi.nlm.nih.gov/26246395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10787-015-0239-Y

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38561490&oldid=1767147265"